AMY RICKER: Open Payments
NPI 1740557677 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$745 in 26 payments from 16 companies in 2025. Trend: 2023 $424 · 2024 $637 · 2025 $745
Food & beverage: $745
| Company | Payments | Amount |
|---|---|---|
| SOBI, INC | 1 | $120 |
| Medtronic, Inc. | 1 | $104 |
| ABBVIE INC. | 4 | $93 |
| Lilly USA, LLC | 4 | $80 |
| Amgen Inc. | 3 | $56 |
| Corcept Therapeutics | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| ViiV Healthcare Company | 1 | $29 |
| Novo Nordisk Inc | 1 | $25 |
| Abbott Laboratories | 1 | $24 |
Products named: SYMPLICITY G3, MOUNJARO, EVENITY, Korlym, QULIPTA, APRETUDE, BOTOX, AIRSUPRA.
Industry payments across MD — which companies pay providers there.
